FTAG 2000 said:
I don't read the article as SAVA has done anything wrong.
If the allegations are proven true, they are saying the entire premise of the protein causing Alzheimer's is illegitimate.
Given that's what SAVA has targeted and put all their work into, that would be a problem for them if found credible.
Now, their drug could still work, but if this theory is thrown in the trash by the NIH then it's absolutely going to have a negative impact on Cassava.
Agree with SAVA not having done anything wrong, and a probe would likely show that.
But if it's shown that the researchers falsified data in the initial Science article from 2006 - and it looks like that's the case - it is devastating to all of the pharmaceutical research done since then.
It could have ripple effects on not just SAVA, but any pharma currently doing amyloid protein work.
If Science comes out and retracts papers, there'll be a big drop in a number of stocks but especially SAVA, I think.
Class of 1998;
Husband of an Aggie, Class of 1999;
Father to future Class of 2029 and 2031
No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. See full
Medical Disclaimer.